Clinical trial
Field Study of the Pharmacokinetics and Pharmacodynamics of Artemisinin-based Combination Therapy for Gametocyte Clearance and Post-treatment Chemoprotection in Zambian Children With Uncomplicated Falciparum Malaria
NCT04009343 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Field Study of the Pharmacokinetics and Pharmacodynamics of Artemisinin-based Combination Therapy for Gametocyte Clearance and Post-treatment Chemoprotection in Zambian Children With Uncomplicated Falciparum Malaria
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Phase
- Phase 2/3
- Overall status
- Active, not recruiting
- Start date
- June 19, 2019
- Completion date
- December 31, 2026
- Enrollment
- 182 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
uncomplicated falciparum malaria